Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: evaluation of safety and efficacy.
Nicola NicolaiSebastiano NazzaniAntonio TesoneAlberto MacchiLuigi PivaRoberto SalvioniSilvia StagniTullio TorelliEdoardo AgostiniFrancesco CelsoPatrizia GiannatempoGiuseppe ProcopioBarbara AvuzziRodolfo LanocitaLaura CattaneoMario CatanzaroDavide BiasoniPublished in: Tumori (2022)
Primary RPLND is safe in stage II GCT, including seminoma, and may warrant a cure rate greater than 70%. When feasible, L-RPLND may be as effective as O-RPLND with better tolerability.